Drug intelligence / Profile preview

hydroquinone + tretinoin

Development stage
Unknown
Lead developer
Galderma
Modality
Small Molecules
Administration
Topical
01

Overview

Hydroquinone + tretinoin is a topical pharmaceutical combination used primarily for the treatment of **hyperpigmentation disorders** such as melasma, post-inflammatory hyperpigmentation, age spots, and freckles. **Hydroquinone** is a skin-lightening agent that works by inhibiting *tyrosinase*, the key enzyme in melanin synthesis, thus reducing pigment production and fading dark spots. **Tretinoin** is a synthetic retinoid (vitamin A derivative) that normalizes keratinization, stimulates skin cell turnover, and increases epidermal regeneration, thereby aiding even skin tone and texture. It also enhances the penetration and efficacy of hydroquinone. The combination is typically prescribed as either compounded formulations or as separate creams, and is usually applied topically to affected areas under medical supervision. Prolonged usage of hydroquinone is not recommended due to risks such as ochronosis and contact dermatitis. The combination may also synergize with corticosteroids (as in triple therapy formulas) to mitigate irritation and inflammation[1][2][3][8][12].

02

Targets

TYR (Tyrosinase)RARA (Retinoic acid receptor alpha)

Beyond the preview

Go deeper on hydroquinone + tretinoin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydroquinone + tretinoin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call